[1]
“Study of the use of zoledronic acid in pediatric patients with osteogenesis imperfecta at the Fernandes Figueira Institute (IFF/Fiocruz)”, RSD, vol. 15, no. 1, p. e0615150474, Jan. 2026, doi: 10.33448/rsd-v15i1.50474.